Through network pharmacology, single-cell transcriptomics, and functional assays, we demonstrate that QZD suppresses NPC progression via apoptosis induction, PI3K-Akt pathway inhibition, and modulation of the tumor immune microenvironment. This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.